Stroke Trial, Recruiting NCT06391086 Sponsor: National Taiwan University Hospital Condition: Stroke
Back to Stroke

Stroke Trial, Recruiting

NCT06391086
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who have been diagnosed with a stroke (either a bleed in the brain or a blockage of blood flow) by a qualified doctor.
  • People whose stroke happened within the last three months.
  • People whose arm muscle strength is rated at 4 points or below on a standard medical muscle strength scale.
  • People with no previous history of stroke, epilepsy, dementia, Parkinson's disease, or other diseases that affect the nervous system over time.
  • People who are able to sit upright in a chair for more than 15 minutes.
  • People aged 18 or older.

Who may not be able to join:

  • People who have had more than one stroke, a brain injury, a brain tumour, a spinal cord injury, Parkinson's disease, or other conditions affecting the muscles or skeleton that could interfere with assessment or treatment.
  • People for whom focused ultrasound treatment is not safe, including those who are pregnant, have a pacemaker or other implanted medical device, have certain connective tissue diseases, have blood clotting problems, have implants near or in the brain, or are considered unsuitable by their doctor.
  • People who cannot cooperate with treatment or assessments due to reduced consciousness or difficulty with speech, or who are unable to give informed consent.
  • People whose skull structure would prevent the ultrasound from passing through to the brain (confirm with trial site).
  • People taking blood-thinning medications who also have blood clotting problems based on specific lab results.
  • People for whom a CT scan would not be safe or suitable.
  • People with major physical illnesses or significant neurological conditions, such as epilepsy or a history of brain surgery.
  • People who have any metal implants in their body.
  • People currently taking tricyclic antidepressants, certain pain medications, or anti-seizure medications.
  • People who experience sleep problems during the ultrasound treatment sessions.
  • People with a history of alcohol dependency.
  • People with severe or uncontrollable high pressure in the brain.
  • People who require ongoing blood-thinning medication.
  • People with any growth or abnormal mass inside the skull.
  • People whose pre-treatment CT scan shows significant calcium build-up in the blood vessels of the brain.
  • People who have wounds or skin damage on the scalp in the area where the treatment would be applied.

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 28 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Meng Ting Lin, M.D., National Taiwan University Hospital

Phone: +886-2312-3456

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
1 August 2024
Est. completion
1 October 2029

Where this trial is recruiting

🇹🇼 Taiwan

Primary endpoints

Incidence of Treatment-related Adverse Events; Cortical excitability

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov